Biosimilar drug by Mylan, Biocon gets USFDA approval

Biosimilar drugs are identical copy of highly complex biologic drugs that claim to have the same efficacy as that off the innovator ’s version.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news